Free Trial

Stock Traders Buy Large Volume of UiPath Call Options (NYSE:PATH)

UiPath logo with Computer and Technology background

UiPath, Inc. (NYSE:PATH - Get Free Report) saw unusually large options trading activity on Wednesday. Stock traders purchased 28,800 call options on the company. This represents an increase of 59% compared to the average volume of 18,108 call options.

Insider Buying and Selling

In related news, CEO Daniel Dines sold 45,000 shares of the stock in a transaction on Friday, July 18th. The shares were sold at an average price of $12.38, for a total value of $557,100.00. Following the transaction, the chief executive officer directly owned 4,968,376 shares of the company's stock, valued at $61,508,494.88. This trade represents a 0.90% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Ashim Gupta sold 56,322 shares of the firm's stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $12.72, for a total transaction of $716,415.84. Following the transaction, the chief financial officer directly owned 859,991 shares in the company, valued at $10,939,085.52. The trade was a 6.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 695,117 shares of company stock worth $8,716,844. 23.19% of the stock is owned by company insiders.

Institutional Trading of UiPath

Large investors have recently modified their holdings of the company. AdvisorNet Financial Inc boosted its holdings in shares of UiPath by 320.4% in the second quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company's stock valued at $32,000 after acquiring an additional 1,887 shares in the last quarter. Versant Capital Management Inc grew its stake in shares of UiPath by 198.6% in the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock worth $31,000 after purchasing an additional 1,970 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of UiPath by 141.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company's stock worth $38,000 after purchasing an additional 1,742 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of UiPath by 48.0% in the 2nd quarter. GAMMA Investing LLC now owns 2,989 shares of the company's stock worth $38,000 after purchasing an additional 969 shares during the last quarter. Finally, CX Institutional acquired a new position in shares of UiPath in the 1st quarter worth approximately $36,000. Institutional investors and hedge funds own 62.50% of the company's stock.

UiPath Stock Up 1.8%

Shares of UiPath stock traded up $0.22 during trading hours on Friday, hitting $12.55. The company's stock had a trading volume of 16,523,646 shares, compared to its average volume of 10,364,601. UiPath has a 1-year low of $9.38 and a 1-year high of $15.93. The business has a fifty day moving average of $12.75 and a 200 day moving average of $12.45. The company has a market capitalization of $6.71 billion, a PE ratio of -104.57, a P/E/G ratio of 16.49 and a beta of 1.04.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The company reported $0.11 EPS for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The firm had revenue of $356.62 million for the quarter, compared to the consensus estimate of $332.17 million. During the same period in the prior year, the firm posted $0.13 EPS. The firm's revenue was up 6.4% compared to the same quarter last year. On average, sell-side analysts anticipate that UiPath will post -0.17 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

PATH has been the topic of a number of research analyst reports. Evercore ISI boosted their price objective on shares of UiPath from $11.00 to $15.00 and gave the stock an "in-line" rating in a report on Friday, May 30th. Mizuho decreased their price objective on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. BMO Capital Markets boosted their price objective on shares of UiPath from $11.50 to $15.50 and gave the stock a "market perform" rating in a report on Friday, May 30th. Morgan Stanley boosted their price objective on shares of UiPath from $12.00 to $15.00 and gave the stock an "equal weight" rating in a report on Monday, June 2nd. Finally, Barclays reissued an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, UiPath presently has an average rating of "Hold" and an average target price of $13.83.

View Our Latest Analysis on PATH

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines